Immunovant

Immunovant is a New York-based biopharmaceutical company that develops and commercializes therapies for the treatment of autoimmune diseases.

Business Model:

Revenue: $0

Employees: 51-200

Detailed Immunovant Information

Geographic Data

Immunovant headquarters map

Address: 320 W 37th Street

City: New York

State: NY

Zip: 10018

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$200M

Raised Total:

$200M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Immunovant is a New York-based biopharmaceutical company that develops and commercializes therapies for the treatment of autoimmune diseases.

Contact Phone:

Contact Email:

Immunovant went public on 4/14/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/14/2020

Ticker Symbol:
IMVT

IPO Price:
$14.5/share

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research